What is Wall Street's Target Price for Vascular Biogenics Ltd (VBLT) Stock Friday?

Friday, January 14, 2022 10:50 AM | InvestorsObserver Analysts

Mentioned in this article

What is Wall Street's Target Price for Vascular Biogenics Ltd (VBLT) Stock Friday?

Analysts who follow Vascular Biogenics Ltd (VBLT) on average expect it to climb 253.92% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns the stock an Analyst Ranking of 74, which means it ranks higher than 74 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating VBLT a Strong Buy today. Find out what this means to you and get the rest of the rankings on VBLT!

See Full VBLT Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Vascular Biogenics Ltd Stock Today?

Vascular Biogenics Ltd (VBLT) stock has risen 0.61% while the S&P 500 has fallen -0.44% as of 10:50 AM on Friday, Jan 14. VBLT has gained $0.01 from the previous closing price of $1.64 on volume of 187,989 shares. Over the past year the S&P 500 has risen 22.22% while VBLT has fallen -31.12%. VBLT lost -$0.48 per share the over the last 12 months. Click Here to get the full Stock Report for Vascular Biogenics Ltd stock.